NZ517899A - 4-benzylaminoquinoline conjugates with bile acid and their heteroanalogues, methods for producing the same, medicaments containing these compounds and their use - Google Patents

4-benzylaminoquinoline conjugates with bile acid and their heteroanalogues, methods for producing the same, medicaments containing these compounds and their use

Info

Publication number
NZ517899A
NZ517899A NZ517899A NZ51789900A NZ517899A NZ 517899 A NZ517899 A NZ 517899A NZ 517899 A NZ517899 A NZ 517899A NZ 51789900 A NZ51789900 A NZ 51789900A NZ 517899 A NZ517899 A NZ 517899A
Authority
NZ
New Zealand
Prior art keywords
alkyl
benzyl
methyl
hydrogen
phenyl
Prior art date
Application number
NZ517899A
Other languages
English (en)
Inventor
Armin Hofmeister
Eugen Falk
Heinz-Werner Kleemann
Hans-Willi Ansen
Martin Bickel
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1999145385 external-priority patent/DE19945385A1/de
Priority claimed from DE2000128193 external-priority patent/DE10028193A1/de
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of NZ517899A publication Critical patent/NZ517899A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • C07J41/0061—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives one of the carbon atoms being part of an amide group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Quinoline Compounds (AREA)
NZ517899A 1999-09-22 2000-09-06 4-benzylaminoquinoline conjugates with bile acid and their heteroanalogues, methods for producing the same, medicaments containing these compounds and their use NZ517899A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE1999145385 DE19945385A1 (de) 1999-09-22 1999-09-22 Substituierte 4-Benzylaminochinoline und ihre Heteroanlagen, Verfahren zu ihrer Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
DE2000128193 DE10028193A1 (de) 2000-06-09 2000-06-09 Substituierte 4-Benzylamminochinoline und ihre Heteroanalogen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikamente oder Diagnostika, sowie sie enthaltende Medikamente
PCT/EP2000/008691 WO2001021642A1 (de) 1999-09-22 2000-09-06 4-benzylaminochinoline konjugaten mit gallensaeure und ihre heteroanalogen, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und deren anwendung

Publications (1)

Publication Number Publication Date
NZ517899A true NZ517899A (en) 2004-03-26

Family

ID=26005994

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ517899A NZ517899A (en) 1999-09-22 2000-09-06 4-benzylaminoquinoline conjugates with bile acid and their heteroanalogues, methods for producing the same, medicaments containing these compounds and their use

Country Status (26)

Country Link
US (1) US6339077B1 (enExample)
EP (1) EP1218401B1 (enExample)
JP (1) JP4833471B2 (enExample)
KR (1) KR20030010575A (enExample)
CN (1) CN1158299C (enExample)
AT (1) ATE269352T1 (enExample)
AU (1) AU779412B2 (enExample)
BR (1) BR0014233A (enExample)
CA (1) CA2385445A1 (enExample)
CZ (1) CZ2002992A3 (enExample)
DE (1) DE50006842D1 (enExample)
DK (1) DK1218401T3 (enExample)
EE (1) EE200200143A (enExample)
ES (1) ES2218222T3 (enExample)
HK (1) HK1049169B (enExample)
HR (1) HRP20020238A2 (enExample)
HU (1) HUP0203045A3 (enExample)
IL (1) IL148739A0 (enExample)
NO (1) NO20021337L (enExample)
NZ (1) NZ517899A (enExample)
PL (1) PL353992A1 (enExample)
PT (1) PT1218401E (enExample)
RU (1) RU2247125C2 (enExample)
SK (1) SK3862002A3 (enExample)
WO (1) WO2001021642A1 (enExample)
YU (1) YU19302A (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6576644B2 (en) 2000-09-06 2003-06-10 Bristol-Myers Squibb Co. Quinoline inhibitors of cGMP phosphodiesterase
ITMI20021025A1 (it) * 2002-05-14 2003-11-14 Nicox Sa Farmaci per il trattamento acuto di disfunzioni del circolo venoso epatico e portale
CZ301037B6 (cs) * 2007-09-06 2009-10-21 Vysoká škola chemicko-technologická v Praze Amidové konjugáty steroidních a žlucových kyselin s D-glukosaminem a zpusob jejich prípravy
ES2488821T3 (es) * 2009-03-24 2014-08-29 Abbvie Bahamas Ltd. Proceso de preparación de un compuesto antiviral
PH12012501846A1 (en) * 2010-04-02 2013-02-04 Firmenich Incorporated Sweet flavor modifier
RU2617700C2 (ru) 2011-08-12 2017-04-26 Синомикс, Инк. Производные 4-аминохинолин-3-карбоновой кислоты и содержащие их композиции для усиления сладкого вкуса
BR112017008738B1 (pt) 2014-11-07 2021-06-15 Firmenich Incorporated Ácidos 4-amino-5-(ciclohexilóxi)quinolina-3-carboxílicos substituídos como modificadores de sabores adoçantes
WO2020041673A1 (en) 2018-08-23 2020-02-27 President And Fellows Of Harvard College Compositions and methods related to cholic acid-7-sulfate as a treatment for diabetes
WO2020117945A1 (en) 2018-12-04 2020-06-11 President And Fellows Of Harvard College Synthetic derivatives of cholic acid 7-sulfate and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4789678A (en) * 1986-08-25 1988-12-06 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing α-alkyl-4-amino-3-quinolinemethanols and 1-(4-aralkylamino-3-quinolinyl)alkanones and related compounds
JPH0667846B2 (ja) * 1989-04-28 1994-08-31 一 滝川 利胆剤
IT1259419B (it) * 1991-05-24 1996-03-18 Erba Carlo Spa Steroidi 3-carbossi 17b - sostituiti insaturi utili come inibitori della testosterone 5 a reduttasi
TW289021B (enExample) * 1993-05-08 1996-10-21 Hoechst Ag
IT1274000B (it) * 1994-04-06 1997-07-14 Alfa Wassermann Spa Derivati di acidi biliari utili nella terapia della calcolosi biliare da colesterolo e nelle patologie indotte da colestasi
DE4432708A1 (de) 1994-09-14 1996-03-21 Hoechst Ag Modifizierte Gallensäuren, Verfahren zu ihrer Herstellung und ihre Verwendung
JPH09315979A (ja) * 1996-05-24 1997-12-09 Tokyo Tanabe Co Ltd 利胆剤
WO1998056757A1 (fr) * 1997-06-11 1998-12-17 Sankyo Company, Limited Derives de benzylamine

Also Published As

Publication number Publication date
EP1218401B1 (de) 2004-06-16
DK1218401T3 (da) 2004-10-04
RU2247125C2 (ru) 2005-02-27
CA2385445A1 (en) 2001-03-29
HRP20020238A2 (en) 2004-04-30
IL148739A0 (en) 2002-09-12
YU19302A (sh) 2004-11-25
WO2001021642A1 (de) 2001-03-29
EE200200143A (et) 2003-04-15
HK1049169B (zh) 2005-04-22
AU7515600A (en) 2001-04-24
BR0014233A (pt) 2002-05-21
PT1218401E (pt) 2004-10-29
AU779412B2 (en) 2005-01-20
US6339077B1 (en) 2002-01-15
SK3862002A3 (en) 2003-01-09
CZ2002992A3 (cs) 2002-06-12
ATE269352T1 (de) 2004-07-15
JP4833471B2 (ja) 2011-12-07
NO20021337L (no) 2002-05-15
NO20021337D0 (no) 2002-03-18
PL353992A1 (en) 2003-12-15
CN1158299C (zh) 2004-07-21
KR20030010575A (ko) 2003-02-05
HUP0203045A3 (en) 2004-06-28
ES2218222T3 (es) 2004-11-16
HK1049169A1 (en) 2003-05-02
CN1374968A (zh) 2002-10-16
HUP0203045A2 (hu) 2003-01-28
EP1218401A1 (de) 2002-07-03
DE50006842D1 (de) 2004-07-22
JP2003510255A (ja) 2003-03-18

Similar Documents

Publication Publication Date Title
JP4616479B2 (ja) 胆汁酸で置換されたフェニルアルケノイルグアニジン類、その製造方法、その薬剤または診断薬としての使用、およびそれらを含有する薬剤
SK282080B6 (sk) Substituované salicylové kyseliny a ich použitie
JPH04308587A (ja) イミダゾ−ル誘導体およびその製法
JP2008515998A (ja) 化合物
JP2003503490A (ja) インドール誘導体およびとりわけ骨粗鬆症の治療のためのそれらの使用
IL94819A (en) History of B11-Aryl-4-Asterin, processes for their preparation and pharmaceutical preparations containing them
NZ517899A (en) 4-benzylaminoquinoline conjugates with bile acid and their heteroanalogues, methods for producing the same, medicaments containing these compounds and their use
NO167570B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive flavonforbindelser.
KR100276528B1 (ko) 심장혈관계 질환에 유효한 17-(3-푸릴) 또는 17-(4-피리다지닐)-5베타,14베타-안드로스탄 유도체와 그들의 제조방법 및 이를 함유하는 약제조성물
US6451781B1 (en) Substituted acylguanidines, process for their preparation, their use as medicaments or diagnostics, and medicaments comprising them
EP0742214B1 (en) Seco-D steroids active in the cardiovascular system and pharmaceutical compositions containing same
JP5845274B2 (ja) 生物学的特性を賦与されたジテルペノイド誘導体
WO2017211271A1 (zh) 一种肾外髓质分泌钾通道抑制剂的可药用盐
ES2372306T3 (es) 4-cromenonil-1,4-dihidropiridincarbonitrilos y su uso.
US5371227A (en) Quinoline derivatives, process for their preparation, and their therapeutic applications
HU229135B1 (en) Benzofurane derivatives
NO178496B (no) Kinolin-2-yl-metoksybenzylhydroksyurea
SK107394A3 (en) Quinoline compounds, method of their preparation and pharmaceutical preparation which containing these compounds
DE10028193A1 (de) Substituierte 4-Benzylamminochinoline und ihre Heteroanalogen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikamente oder Diagnostika, sowie sie enthaltende Medikamente
CN117946199A (zh) 一种屈螺酮关键中间体的制备方法
EP2070909A1 (de) Nichtsteroidale Progesteronrezeptor-Modulatoren
JPWO1998011124A1 (ja) ３−置換−ｄ−ホモ−１，３，５，（１０）−エストラトリエン誘導体
NO781792L (no) Fremgangsmaate for fremstilling av n-(3`-fenyltiopropyl)-3,3-difenylpropylamin

Legal Events

Date Code Title Description
ASS Change of ownership

Owner name: AVENTIS PHARMA DEUTSCHLAND GMBH, DE

Free format text: OLD OWNER(S): AVENTIS PHARMA DEUTSCHLAND GMBH

PSEA Patent sealed
RENW Renewal (renewal fees accepted)